• About
  • Subscribe
  • Advertise
  • Contact
Saturday, May 24, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Uncategorized

Highlights from O=MEGA23/WCO4

by Myles Hume
September 11, 2023
in Conferences, Events, International, Local, News, Uncategorized, VIC
Reading Time: 6 mins read
A A
O=MEGA23/WCO4 took place at the Melbourne Convention and Exhibition Centre 8-10 September.

O=MEGA23/WCO4 took place at the Melbourne Convention and Exhibition Centre 8-10 September.

Share on FacebookShare on Twitter

As the dust settles from the combined O=MEGA23 and 4th World Congress of Optometry, organisers are hailing the success of the three-day event featuring more than 3,500 attendees, various product launches and a thought-provoking clinical program with some of the latest insights on myopia and other conditions.

The collaboration with the World Council of Optometry (WCO) meant this year’s event had a distinct international flavour – and the industry responded with around 200 international delegates, and WCO president Professor Peter Hendicott – an Australian – delivering an important update on global efforts to lift eyecare quality and accessibility.

World Council of Optometry president Prof Peter Hendicott delivering his presentation during the opening plenary.

Several high-ranking figures flew into Melbourne from 8-10 September, signifying the importance of the Australian market to their global ophthalmic businesses. Tokai Optical, who welcomed president Mr Hirokazu Furuzawa from Okazaki city in Japan, Eyetelligence with new US-based CEO Mr Jeff Dunkel, and two key figures from Rodenstock HQ in Germany were just some examples.

Myopia generated some of the liveliest discussions in the clinical conference program and masterclass sessions.

Tokai Optical president Mr Hirokazu Furuzawa with general manager for Australia Justin Chiang, and Takanori Tanaka, also from Japan.

Most notably, a presentation from Mr Jim Papas on the new TGA-approved repeated low-level red light (RLRL) therapy from Australian firm Eyerising International received numerous questions from myopia authorities such as Drs Kate and Paul Gifford, while details of a new “breakthrough” soft contact lens for myopia control by Johnson & Johnson Vision, presented by Dr Noel Brennan, almost filled the Goldfields Theatre. In addition, Specsavers ANZ head of professional services Dr Joe Paul delivered the latest update on myopia prevalence in Australia and New Zealand.

“This is exactly what these sessions are about. It’s a forum to hear directly from researchers and industry, and drill down into topics with back-and-forth discussions,” Optical Distributors and Manufacturers Association (ODMA) CEO Ms Amanda Trotman said.

“And for anyone who is launching a product, it’s an opportunity for them to hear feedback or what the concerns may be, so they can work to address them on the spot and through their marketing.”

Specsavers ANZ head of professional services Dr Joe Paul delivering his presentation on myopia prevalence in the region.
Dr Noel Brennan presenting on Johnson & Johnson’s new myopia control soft contact lens design.

On the Friday there were around 2,500 people on site, comprising 900 delegates, 1,200 trade fair attendees and around 400 industry figures. Saturday saw around 800 visitors, and on Sunday approximately 600 were expected.

“When you add that up, that’s well over 3,500 over the three days,” Trotman said.

“The numbers have been great. We have had around 200 international visitors, with around 70 from our friends in New Zealand, and the conference had around 1,100 attendees, which is what we targeted, especially given the amount of CPD that is available online and through other channels today.”

Amanda Trotman, ODMA.

On the trade fair, Trotman said the quality of the exhibits “blew her away”. After looking at the trade hall as an A4 sheet of paper for the last two years, she was amazed to see the 9,000sqm space come to life, with noticeable investments from industry suppliers to spark those important conversations with key purchasing decision makers within optical practices.

“There has been a buzz in the hall throughout … and there has been nothing but positive feedback. I’ve even received a text to say, ‘great show Amanda, actually the best one ever’, so I’m thrilled,” she said.

“Every exhibitor is here for a different reason; some to sell, some for band awareness and others to catch up with existing clients. Everyone is saying they’ve had very good days, and interestingly some days were busier for equipment companies vs frames companies – and we think that’s to do with purchase decisions. The first day delegates were so busy, seeking out certain equipment companies, but coming back a day or two later for a follow up, while the frames companies were really busy Saturday, with people bringing back their bosses for those final decisions.”

Companies like EssilorLuxottica, OptiMed, HOYA and Wymond-owned Eyes Right Optical, Modstyle and Sunglass Collective were dominant forces on the trade floor, but some of the smaller stands, like The Elusive Miss Lou, were innovative in their approach.

“I haven’t seen a time when there isn’t eight people at The Elusive Miss Lou booth,” Trotman said.

The trade floor occupied 9,000sqm.

The combined Eyetelligence and Eyerising International stand was also a hive of activity, with attendees interested in some of the most cutting edge technology to hit the ophthalmic scene. The Australian-based companies have a common link through Professor Mingguang He and have developed, respectively, an artificial intelligence system that screens for referable eye diseases, and the new RLRL therapy that has just been approved for myopia management in Australia.

The event was a key opportunity for Rodenstock to demonstrate the benefits of its DNEye Scanner device to produce customised lenses for patients.

“This is my first optometry meeting in this format – and I didn’t know what to expect,” Dunkel, Eyetelligence’s CEO who flew in from the US, said.

“But I’ve come down and our booth has been packed with visitors from small practices, giant practices, peers and societies. There is a genuine curiosity which I interpret to be really important and means we are in a good place to move towards our long-term goal of adoption to benefit patients and clinicians.”

Mr Mark Wymond, CEO and managing director of Eyes Right Optical, Modstyle and Sunglass Collective, was a major exhibitor and happy with the conversations he had with visitors. Eyewear supplied by his companies picked up three categories in the ODMA Awards for Excellence program, capping off a successful event.

Project Green was a feature of the Eyes Right Optical booth, a new high-end, environmentally-friendly collection that doesn’t compromise on quality, style, look, or feel.

“It’s been a great chance to connect with so many businesses that would usually take me a month to get around and see, so it’s been very valuable from our perspective,” he said.

“We have spoken to a lot of key decision makers and buying groups, and when you’re releasing so much new product, it is great to get it out to so many people this quickly. All in all, it’s been a great show and we are happy to support it in a large way – it’s always been good to us.”

Poster sessions provided an opportunity for delegates to understand some of the latest optometric research.

O=MEGA23 marked the launch of Cylite’s Australian-made HP-OCT, and the company’s CEO Ms Kylee Hall was encouraged by the level of interest in the device. This includes a strong delegation of optometrists operating in the specialty contact lens space, but also larger practice owners, as well as new practice owners, seeking a multi-functional instrument offering OCT, topography, axial length measurement, and more, to save on space.

The Essilor Vision-R 800 auto phoropter was a major attraction on the OptiMed stand.

“For us, this is the official launch. People have been following us for a long time and it’s now nice to say the device is ready for orders and delivery at end of the year. It’s also been an opportunity for us to talk about the uniqueness of our technology, and when people sit down and look at images, they start to realise why it’s so different,” she said.

Mr John Larkin, from ophthalmic equipment supplier OptiMed, said after the absence of an event of this size for some four years, optometrists were keen to have hands on experience with the latest tech that has been released during that time.

“People have been visiting the booth with a genuine interest. With the pandemic largely behind us, we can see they are in a position to invest, especially those from well-established practices,” he said.

Masterclass sessions engaged practice managers and dispensers in the educational schedule.

More reading

ODMA Awards for Excellence 2023 winners announced

Eyes Right Optical shaking up sustainable eyewear with Project Green

OSHOW’s Sydney success could see event return to city for 2024

Related Posts

Jillian Campbell, performing as many as 20 contact lens fits a day, relies on the Medmont Merdia Pro for most of her work.

The workhorse of this contact lens practice

by Staff Writer
May 24, 2025

The next-generation Meridia Pro boasts all the advantages Medmont corneal topography is famous for, plus more. Independents like JILLIAN CAMPBELL...

Rodenstock’s new B.I.G. Exact Sensitive lenses are now available in Australia. Image: Rodenstock.

Try before you buy – a personal, exacting trial for Rodenstock lenses

by Rob Mitchell
May 23, 2025

Rodenstock has made some significant statements about its new B.I.G Exact Sensitive lenses. The director of a Melbourne optometry practice...

The Eyerising Myopia Management Device was approved in Australia in 2023. Image: Eyerising International.

Eyerising International addresses ‘limitations’ of red light study suggesting reduced cone density  

by Staff Writer
May 23, 2025

The inventor of the Eyerising International repeated low-level red light (RLRL) therapy for myopia, Professor Mingguang He, has outlined “notable...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited